Literature DB >> 27725708

The rs6771157 C/G polymorphism in SCN10A is associated with the risk of atrial fibrillation in a Chinese Han population.

Zhen Fang1,2, Yue Jiang3, Yifeng Wang3, Yuan Lin3, Yaowu Liu4, Liyan Zhao2, Yan Xu2, Mohammad Bilaal Toorabally2, Shenghu He1, Fengxiang Zhang2.   

Abstract

A recent genome wide associated study in European descent population identified the association of Atrial fibrillation (AF) risk with a single nucleotide polymorphism (SNP) in SCN10A. The aim of this study was to evaluate whether SCN10A polymorphisms are associated with AF risk in the Chinese Han population. A total of 2,300 individuals of Chinese Han origin were recruited and three potentially functional SNPs were genotyped. Logistic regression models were utilized to calculate odds ratios (ORs) at a 95% confidence intervals (CIs). Logistic regression analysis in an additive genetic model revealed that one SNP in SCN10A (rs6771157) was associated with an increased risk of AF (adjusted OR = 1.20, 95% CI: 1.06 - 1.36, P = 0.003). Stratification analysis of several main AF risk factors indicated that the risk associations with rs6771157 were not statistically different among different subgroups. In summary, our study suggests the possible involvement of the SCN10A variant in AF development in Chinese Han populations. Further biological function analyses are required to confirm our finding.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27725708      PMCID: PMC5057108          DOI: 10.1038/srep35212

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


Atrial fibrillation (AF), one of the most prevalent arrhythmia in clinical practice, affects 1–2% of the general population1. AF is related to a five-fold increased risk of stroke2, a three-fold increase in incidence of congestive heart failure3 and a two-fold increase in mortality rate45, which contribute to higher hospitalization rate in AF patients3. The occurrence of AF is usually considered to be associated with multiple cardiovascular risk factors, such as advanced age, male, hypertension, diabetes, heart failure, and hyperthyroidism467. However, a small part of the patients with AF lack the clinical evidence of risk factors. We named this type of AF as ‘lone AF’, which account for 10–20% of the total AF8. Several studies have demonstrated that AF, especially lone AF, have a predisposing genetic component9101112. Over the past decade, multiple genetic variants, including common and rare genetic variants, had been reported to be associated with susceptibility to AF131415. In 2010, a genome-wide association study (GWAS) by Pfeufer et al. detected an intronic SNP (rs6800541) in SCN10A that is independently associated with PR-interval and AF risk (P = 9.7 × 10−82, P = 0.5 × 10−4, respectively)16. A meta-analysis of 14 GWASs discovered that another intronic SNP (rs6801957) in SCN10A may be a major risk marker for prolonged QRS duration in individuals of European descent17. Further functional analyses have confirmed that SCN10A was expressed in human ventricular conduction system and the loss of SCN10A had an apparent impact on both PR interval and QRS duration in mouse models1718. These facts indicate that SCN10A may be involved in the development of AF. In this study, we employed candidate gene approach to identify potentially functional AF susceptibility SNPs in SCN10A in Chinese Han populations.

Results

Characteristics of the Study Population

We recruited 2,300 individuals of Chinese Han origin in this study totally, including 1,150 AF cases and 1,150 AF-free controls. The clinical characteristics between cases and controls are summarized in Table 1. In brief, the variants of gender and age in two groups were comparable (P > 0.05). Compared with the non-AF subjects, AF patients were more likely to have the percentages of hypertension, diabetes and coronary artery disease (CAD) (45.1% vs. 20.8%, P < 0.001 for hypertension, 10.5% vs. 7.5%, P = 0.011 for diabetes and 10.3% vs. 0%, P < 0.001 for CAD, respectively).
Table 1

Clinical characteristics of the Chinese Han study population.

VariantsCasesControlsP value
(N = 150)(N = 150)
Male gender (%)757(65.8%)757(65.8%)1
Age, years58.7 ± 11.559.1 ± 10.50.379
Paroxysmal AF (%)559 (48.6%)NA
Persistent AF (%)591(51.4%)NA
Lone AF (%)152(13.2%)NA
Hypertension (%)519 (45.1%)239 (20.8%)<0.001
Diabetes (%)121 (10.5%)86 (7.5%)0.011
CAD (%)118 (10.3%)0 (0.0%)<0.001

AF, atrial fibrillation; CAD, coronary artery disease; NA, not available.

Associations between SCN10A variants and AF risk

The genotype distributions of the three SNPs and their associations with AF risk are shown in Table 2. The genotype frequencies of these SNPs were all observed in agreement with Hardy–Weinberg equilibrium in the control group. The logistic regression analyses revealed that the rs6771157 C allele was significantly associated with the increased risk of AF in an additive model (adjusted OR = 1.20, 95% CI: 1.06–1.36, P = 0.003). We further calculated P values for false discovery rate (P-FDR) to perform multiple comparisons, which found that rs6771157 still remained association with the risk of AF (P-FDR = 0.010). There was no obvious evidence of significant association between the other two SNPs and AF risk.
Table 2

Summary of associations between 3 SNPs in SCN10A and the risk of AF.

SNPPositionMinor/majorGenotype distributiona
MAF
Crude ESb
Adjusted ESc
CasesControlsCasesControlsPHWEOR(95% CI)P ValueOR(95% CI)P ValuePFDRd
rs982794138811463A/T80/444/62687/425/6220.260.260.230.99(0.87–1.13)0.9091.01(0.88–1.16)0.9100.910
rs763098938768944G/A63/360/72759/371/7200.210.210.220.99(0.87–1.14)0.9161.03(0.89–1.19)0.7410.910
rs677115738738867C/G255/581/314217/535/3980.470.420.121.24(1.10–1.39)3.48 × 10−41.20(1.06–1.36)0.0030.010

SNP, single nucleotide polymorphism; MAF, minor allele frequency; PHWE, P values for Hardy–Weinberg equilibrium tests in the control group; ES effect size; OR odds ratio; CI confidence interval.

aGenotype distribution for the minor allele/heterozygous/homozygous.

bES were derived from logistic regression analysis in the additive model for unadjustment of any covariants.

cES were derived from logistic regression analysis in the additive model for adjustment of age, gender, hypertension, diabetes and coronary artery disease.

dMultiple comparisons P values for false discovery rate.

Stratification Analysis

We assessed the effect size of rs6771157 with AF by stratification analyses based on the main AF risk factors such as age, gender, hypertension, diabetes. As shown in Table 3, no significant difference for the association of rs6771157 with AF risk between subgroups was detected (P > 0.05 for heterogeneity test).
Table 3

Stratified analysis on the associations of SNP in SCN10A with AF.

Variablesrs6771157(CC/CG/GG)Adjusted ORa (95% CI)Pb
CasesControls
Agec
 ≤59129/284/16099/271/1971.24 (1.05–1.47)0.850
 ≥60126/297/154118/264/2011.21 (1.00–1.46) 
Gender
 male160/391/206150/344/2631.18 (1.01–1.37)0.576
 female95/190/10867/191/1351.27 (1.03–1.56) 
Diabetes
 Yes26/68/2715/38/331.56 (0.98–2.48)0.256
 No229/513/287202/497/3651.18 (1.04–1.34) 
Hypertension
 Yes112/266/14148/100/911.34 (1.06–1.68)0.366
 No143/315/173169/435/3071.18 (1.02–1.38) 

aObtained in logistic regression models with adjustment for age, gender, hypertension, diabetes and coronary artery disease (the stratified factor in each stratum excluded).

bP for heterogeneity test using the Chi-square-based Q test.

cAge was divided into two subgroups according to its median (59 years).

Discussion

This case-control study investigated the relationship between the common genetic variants of SCN10A and their potential function in the risk of AF in the Chinese Han population. Only SNP rs6771157 was identified to be significantly associated with Chinese Han AF risk. SCN10A encodes the voltage-gated sodium channel, Nav1.8 channels. The protein product of SCN10A is predominant tetrodotoxin-resistant sodium channel in primary sensory neurons1920. Although the exact role of Nav1.8 in cardiac electrophysiology remains currently unclear21, SCN10A is expressed both in intracardiac neurons and human cardiomyocytes2223. Further, blockade of Nav.18 channels suppresses the impact of vagus nerve stimulation (VNS) on both cardiac conduction and AF inducibility232425. Thus, SCN10A plays an important role in cardiac electrophysiology and modulating susceptibility to arrhythmias24. In a previous GWAS. A tag SNP (rs6800541) in SCN10A has been found to have a strong association with PR-interval duration and AF16. Most recently, a function study by Jabbari et al. revealed two common nonsynonymous variants in SCN10A (rs6795970, rs12632942) result in a gain-of-function of Nav1.8 channel21. In the present study, we found an association between another common variant rs6771157 and AF risk in Chinese Han populations. We analyzed the linkage disequilibrium of SNP rs6771157 with the two significant SNPs via haploview software, which showed r2 = 0.1 and 0.171 for rs6800541 and rs6801957 respectively (Fig. 1). Thus, the rs6771157, a synonymous variant located in the 19 exon of SCN10A. is a signal different from the two SNPs reported in European individuals. It was predicted as a functional SNP in an ESE (exon splicing enhancer) by the online tool SNPinfo (http://snpinfo.niehs.nih.gov/index.html), which may be responsible for aberrant splicing of pre-mRNA of SCN10A by binding to the SR proteins of splicing activators26. A possible explanation is that rs6771157 causes the exon skipping by activating the creation of the ESE.
Figure 1

A regional plot of SCN10A gene to characterize the association results and linkage disequilibrium (LD) of the three SNPs.

The pairwise correlation between the SNP rs6771157 and two SNPs (rs6800541, rs6801957) were measured with r2, r2 = 0.1 and 0.171 respectively.

Several limitations of the present study need to be considered. Firstly, the sample size is relatively small compared to GWAS, which may predispose to the failure to detect effects of another two potential functional SNPs in our study. Secondly, echocardiography results and N-terminal of the prohormone brain natriuretic peptide (NT-proBNP) levels were not available for all the individuals to evaluate cardiac functions, which may have resulted in information bias. We did not evaluate cardiac functions by left ventricular ejection fraction (LVEF) and NT-proBNP. Furthermore, we selected the potential functional SNP by using on-line tools, which may result in positive or negative errors. Thus, further replication in larger sample sets and mechanism researches are required to confirm our findings. In conclusion, the current investigation confirmed that one functional common variation (rs6771157) in SCN10A was significantly associated with the risk of AF in a Chinese Han population. However, the role of this variant in the AF susceptibility is warranted to be further evaluated by function studies.

Methods

Study population

This study was approved by Ethical Committee Review Board of Nanjing Medical University, China. The written informed consents were obtained from all the participants enrolled in the study. The experimental protocol was carried out in accordance with the approved guidelines. The AF cases were recruited from Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University from June 2010 to December 2014. We included AF patients according to their routine 12-lead electrocardiography (ECG), or holter ECG recordings which were characterized with irregular R-R intervals, absence of distinct repeating P waves, and irregular atrial activity27. We classified AF as paroxysmal AF (terminates spontaneously or with intervention within 7 days of onset), persistent AF (episodes that sustain beyond 7 days). We defined “Lone AF” as young AF individuals (<60 years) without clinical or echocardiographic evidence of cardiopulmonary disease3. The controls were recruited from other departments of the First Affiliated Hospital of Nanjing Medical University, and they were all confirmed to be free of AF based on medical files or ECG at the time of enrollment. The general and clinical information of all participants was collected from medical recording files in the hospital system. We excluded patients with hyperthyroidism, severe cardiac dysfunction (NYHA Class IV), valvular heart disease and advanced age (beyond 90 years) in AF group. All individuals were Chinese Han origin.

SNP selection

We first used public HapMap SNP database (phase II+III Feb 09, on NCBI B36 assembly, dbSNP b126) to search SNPs that localized within the gene region of SCN10A (including 10 kb upstream of the gene), with MAF (Minor Allele Frequency) ≥ 0.05 in Chinese Han population. Then, a web-based analysis tool was used to predict the function of these SNPs (http://snpinfo.niehs.nih.gov/snpinfo/snpfunc.htm). After function prediction analysis, a total of six potentially functional SNPs were selected. We conducted linkage disequilibrium (LD) analysis to exclude SNPs with strong LD (r2 ≥ 0.8), then three (rs9827941, rs7630989, and rs6771157) functional SNPs were selected for further genotyping.

SNP genotyping

Peripheral venous blood samples were drawn from study participants. Genomic DNA was extracted from EDTA-preserved whole blood using a standard phenol-chloroform method28. The genotyping was conducted using the method of the improved multiple ligase detection reaction (iMLDR) with the technical assistance from Shanghai Genesky Bio-Tech Genetic Core Lab. All SNPs were genotyped successfully with call rates at least of 99.3%.

Statistical analysis

The comparisons of clinical characteristic differences between cases and controls were identified using Student’s t test for continuous variables and the χ2 test for categorical variables. The deviation of genotype distribution from Hardy-Weinberg equilibrium was tested by χ2 test in the control group. ORs and 95% CIs were calculated to assess the relationships between the SNPs and the risk of AF using logistic regression. The heterogeneity of associations among subgroups was evaluated using the χ2-based Q-test. All statistical analyses were performed with STATA 12.0 software (Stata Corp., College Station, TX, USA). P < 0.05 was the criterion of statistical significance and all statistical tests were two-tailed. LD analysis was applied by using Haploview 4.2 software.

Additional Information

How to cite this article: Fang, Z. et al. The rs6771157 C/G polymorphism in SCN10A is associated with the risk of atrial fibrillation in a Chinese Han population. Sci. Rep. 6, 35212; doi: 10.1038/srep35212 (2016).
  28 in total

1.  Functional Nav1.8 channels in intracardiac neurons: the link between SCN10A and cardiac electrophysiology.

Authors:  Arie O Verkerk; Carol Ann Remme; Cees A Schumacher; Brendon P Scicluna; Rianne Wolswinkel; Berend de Jonge; Connie R Bezzina; Marieke W Veldkamp
Journal:  Circ Res       Date:  2012-06-20       Impact factor: 17.367

2.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association.

Authors:  A John Camm; Gregory Y H Lip; Raffaele De Caterina; Irene Savelieva; Dan Atar; Stefan H Hohnloser; Gerhard Hindricks; Paulus Kirchhof
Journal:  Europace       Date:  2012-08-24       Impact factor: 5.214

Review 3.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

Review 4.  Atrial fibrillation: the role of common and rare genetic variants.

Authors:  Morten S Olesen; Morten W Nielsen; Stig Haunsø; Jesper H Svendsen
Journal:  Eur J Hum Genet       Date:  2013-07-10       Impact factor: 4.246

5.  Incidence of and risk factors for atrial fibrillation in older adults.

Authors:  B M Psaty; T A Manolio; L H Kuller; R A Kronmal; M Cushman; L P Fried; R White; C D Furberg; P M Rautaharju
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

6.  Phenol extraction revisited: a rapid method for the isolation and preservation of human genomic DNA from whole blood.

Authors:  C G Albariño; V Romanowski
Journal:  Mol Cell Probes       Date:  1994-10       Impact factor: 2.365

7.  Genetic variation in SCN10A influences cardiac conduction.

Authors:  John C Chambers; Jing Zhao; Cesare M N Terracciano; Connie R Bezzina; Weihua Zhang; Riyaz Kaba; Manoraj Navaratnarajah; Amol Lotlikar; Joban S Sehmi; Manraj K Kooner; Guohong Deng; Urszula Siedlecka; Saurabh Parasramka; Ismail El-Hamamsy; Mark N Wass; Lukas R C Dekker; Jonas S S G de Jong; Michael J E Sternberg; William McKenna; Nicholas J Severs; Ranil de Silva; Arthur A M Wilde; Praveen Anand; Magdi Yacoub; James Scott; Paul Elliott; John N Wood; Jaspal S Kooner
Journal:  Nat Genet       Date:  2010-01-10       Impact factor: 38.330

8.  Familial atrial fibrillation is a genetically heterogeneous disorder.

Authors:  Dawood Darbar; Kathleen J Herron; Jeffrey D Ballew; Arshad Jahangir; Bernard J Gersh; Win-K Shen; Stephen C Hammill; Douglas L Packer; Timothy M Olson
Journal:  J Am Coll Cardiol       Date:  2003-06-18       Impact factor: 24.094

9.  Familial aggregation of atrial fibrillation: a study in Danish twins.

Authors:  Ingrid Elisabeth Christophersen; Lasse Steen Ravn; Esben Budtz-Joergensen; Axel Skytthe; Stig Haunsoe; Jesper Hastrup Svendsen; Kaare Christensen
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-04-23

10.  Localisation of SCN10A gene product Na(v)1.8 and novel pain-related ion channels in human heart.

Authors:  Paul Facer; Prakash P Punjabi; Andleeb Abrari; Riyaz A Kaba; Nicholas J Severs; John Chambers; Jaspal S Kooner; Praveen Anand
Journal:  Int Heart J       Date:  2011       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.